Effect of secretin on bile formation in rats with cirrhosis of the liver: structure-function relationship.
To investigate whether the hypercholeresis seen in cirrhotic humans and animals is due to ductular proliferation or altered inactivation of secretin, or both, we studied the response of bile flow and biliary erythritol clearance to synthetic porcine secretin in rats rendered cirrhotic by chronic exposure to phenobarbital/carbon tetrachloride (n = 11) and untreated control rats (n = 5). Bile duct mass was determined morphometrically. Furthermore, plasma disappearance of secretin was measured by radioimmunoassay. Basal bile flow did not differ between the two groups. Whereas secretin had no effect in the control group, it stimulated bile flow by 49% +/- 33% in the cirrhotic group (p less than 0.001). Erythritol bile-to-plasma ratio was lower and biliary bicarbonate concentration higher in the cirrhotic rats, suggesting some ductular contribution to bile flow even in the absence of secretin. Biliary bicarbonate concentration did not increase further during secretin administration, whereas bile salt concentration decreased from 27 +/- 6 to 18 +/- 4 mM. The elimination half-life of secretin was not affected by cirrhosis, averaging 5 +/- 2 min in both groups. Bile duct volume was increased in cirrhotics (2.9% +/- 1.4% vs. 0.2% +/- 0.1%; p less than 0.01) and showed an excellent correlation with the maximal secretin-induced increment of bile flow. Our results suggest that the proliferating ductules contribute to bile flow and that increased secretin responsiveness is not due to altered pharmacokinetics in cirrhotic rat liver.
Department of Clinical Pharmacology, University of Berne, Switzerland.
J
J
Knuchel
S
S
Krähenbühl
A
A
Zimmermann
J
J
Reichen
D000818:Animals; D001639:Bicarbonates / Q000032:analysis; D001646:Bile / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D001647:Bile Acids and Salts / Q000032:analysis; D004573:Electrolytes / Q000032:analysis; D004896:Erythritol / Q000493:pharmacokinetics; D008099:Liver / Q000473:pathology; D008106:Liver Cirrhosis, Experimental / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012633:Secretin / Q000097:blood / Q000494:pharmacology*; D013395:Sucrose / Q000493:pharmacokinetics
D001639:Bicarbonates; D001647:Bile Acids and Salts; D004573:Electrolytes; D012633:Secretin; D013395:Sucrose; D004896:Erythritol